| nafronyl | <chemical> 2-(diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate oxalate. A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enchance cellular oxidative capacity and to be a spasmolytic. It may also be an antagonist at 5ht-2 serotonin receptors. Pharmacological action: parasympatholytics, serotonin antagonists, vasodilator agents. Chemical name: 2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester (12 Dec 1998) |
|---|---|
| nafronyl oxalate | 2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate oxalate;a vasodilator drug. (05 Mar 2000) |
Synonyms : Abbott Brand of Naftidrofuryl Oxalate, Alpharma Brand of Naftidrofuryl Oxalate, Artocoron, Azunaftil, Azupharma Brand of Naftidrofuryl Oxalate, Di-Actane, Dusodril, Faes Brand of Naftidrofuryl Oxalate, Gevatran, Hexal Brand of Naftidrofuryl Oxalate, LS-121
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Ǫ¶ô½Ç·»Ä°¼¿ - »õâ
|
´ë¿õÁ¦¾à |
A04302311 | Nafronyl oxalate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
µµ³ª¸°Ä°¼¿ - »õâ
|
¸íÀÎÁ¦¾à |
A09200391 | Nafronyl oxalate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
³ªÇª¸±Ä°¼¿ - »õâ
|
ÇÑ¿ÃÁ¦¾à |
A03502201 | Nafronyl oxalate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
³ªµå¸±Ä°¼¿ - »õâ
|
´ë¿ì¾àǰ°ø¾÷ |
A05401571 | Nafronyl oxalate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
µÎ¼Ò¸±Ä¸½¶ - »õâ
|
Çѱ¹¸ÞµðÅØ |
A20500461 | Nafronyl oxalate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
³ªº£·Ðݼ¿ - »õâ
|
ÇѺÒÁ¦¾à |
A22550581 | Nafronyl oxalate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
³ªÇÁƼݼ¿ - »õâ
|
´ëÈÁ¦¾à |
A15600871 | Nafronyl oxalate | Àü¹®ÀǾàǰ | »èÁ¦ |
| nafronyl oxalate |
a vasodilator which has been used in the treatment of peripheral and cerebral vascular disorders.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|